Clinical Study

Studies,trial,clinical trials,diseases,drugs,time,treatments,phase,intervention,events,devices,search,life,clinical study,Observational studies,products,terms,healthy volunteers,behavioral intervention,medical devices,activity,quality of life,evidence,health,health care provider.

Review process,advanced search,locations,blood,notice,placebo,biological products,medical product,cancer,ethics committees,medical care,study sponsor,Participating in Studies,study arm,study completion,study records,submission of study results,interventional study,study protocol,clinical study record,closed studies,commitment studies.

Community studies,microdose studies,observational study models,clinical trial arm,clinical trial design strategy,exploratory trials,masked trial,National Institutes of Health,health outcomes,health care safer,health risks,health services,National Institutes of Health Clinical Center,type of intervention model,surgical intervention,types of interventions,combinations of interventions,intervention arm,pairs of interventions,reviews,QC review,process for review,quality control review criteria,institutional review board,limited review.

NLM quality control review,Food and Drug Administration,U.S. Food and Drug Administration,active drug,drug for marketing,drug in combination,dose,FDA-defined phases,initial phase,Centers for Disease Control and Prevention,patterns of diseases,Medical events,trials of devices,device companies,search feature,search results list,studies with locations,location countries,Location terms field,correction notice,Notice of Noncompliance indicates,penalty notice,eligibility,type of eligibility criteria,gender-based eligibility,status,access status,current recruitment status,investigational treatment,antidepressant treatment,normal life functions,placebo comparator arm,Common Site Terms,location-related terms,volunteer,human volunteers,Major issues,issues,advisory issues,consent,informed consent form,birth defect,age group requirements,key requirements,completion dates,dates,8-digit number,identification code,congenital anomaly,inactive substance,participant in danger,scientific integrity,structured online,subgroup of participants,risk factors,scientific validity,academic journal,basic science,biological distinctions,biomedical or health-related outcomes,default display,dietary supplements,food supply,human research subjects,interventions to participants,participant flow,person’s self-representation,human participants,arm type,access types,supportive care,primary completion,person responsible,initial results submissions,active processes,active comparator arm,clinical research studies,clinical trial applications,clinical trial design,infectious diseases,birth,North Carolina,Pacific Islander,cohort study,Study Participants,longitudinal study,clinical trial sponsors,”National Health System,”,Days after Dose,dose of vaccine,dose in participants,phase Phase,adverse events,Systemic events,Blood Cholesterol,blood of people,collection of blood,Surveillance time,time period,daily activity,interference with activity,placebo recipients,Participants without Evidence,evidence of infection,cancer diagnosis,genomic cancer signals,informed consent document,birth weight,application requirements,overlapping dates.